Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Current Assets: 2019-2022

Historic Current Assets for ADC Therapeutics (ADCT) over the last 3 years, with Dec 2022 value amounting to $435.0 million.

  • ADC Therapeutics' Current Assets fell 14.27% to $375.6 million in Q3 2023 from the same period last year, while for Sep 2023 it was $375.6 million, marking a year-over-year decrease of 14.27%. This contributed to the annual value of $435.0 million for FY2022, which is 17.18% down from last year.
  • Per ADC Therapeutics' latest filing, its Current Assets stood at $435.0 million for FY2022, which was down 17.18% from $525.2 million recorded in FY2021.
  • ADC Therapeutics' 5-year Current Assets high stood at $525.2 million for FY2021, and its period low was $122.6 million during FY2019.
  • Over the past 2 years, ADC Therapeutics' median Current Assets value was $480.1 million (recorded in 2021), while the average stood at $480.1 million.
  • Data for ADC Therapeutics' Current Assets shows a maximum YoY fell of 17.18% (in 2022) over the last 5 years.
  • Yearly analysis of 3 years shows ADC Therapeutics' Current Assets stood at $122.6 million in 2019, then reached $525.2 million in 2021, then fell by 17.18% to $435.0 million in 2022.